ABT logo
ABT@NYSE
Abbott Laboratories
$ 99.60+1.11 (+1.13%)
ABT 매수
시가장 시작 가격
—
저가오늘 최저가
—
52주 최고가최근 52주 최고가
—
고가오늘 최고가
—
52주 최저가최근 52주 최저가
—
시가총액기업 총가치
170.43B
오늘 거래량오늘 거래량
11.94M
평균 거래량평균 거래량
10.74M
주가수익비율 (P/E)주가수익비율
31.67

기업 정보

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

IPO 날짜
1980-03-17
본사
Abbott Park, US
CEO
Robert Ford
섹터
Healthcare
산업
Medical - Devices

재무제표

실적

관련 기업

BDX logo
BDXBecton, Dickinson and Company
183.75
BSX logo
BSXBoston Scientific Corporation
42.73
DHR logo
DHRDanaher Corporation
219.87
EW logo
EWEdwards Lifesciences Corporation
85.21

거래의 미래를 열다

AI 기반 인사이트로 더 스마트하고 자신감 있는 거래를 위한 글로벌 시장에 대한 원활한 액세스.

디바이스 목업